2022
DOI: 10.1016/s1473-3099(22)00290-0
|View full text |Cite
|
Sign up to set email alerts
|

Clinical evaluation of the BioFire Global Fever Panel for the identification of malaria, leptospirosis, chikungunya, and dengue from whole blood: a prospective, multicentre, cross-sectional diagnostic accuracy study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 26 publications
0
6
0
Order By: Relevance
“…Our study identified a case of CCHF that otherwise would not have been detected. Similarly, CCHF was previously identified at the Global Fever panel febrile illness study site in Mubende, Uganda 12,23 . During the 2022 Sudan virus disease outbreak.…”
Section: Discussionmentioning
confidence: 57%
See 1 more Smart Citation
“…Our study identified a case of CCHF that otherwise would not have been detected. Similarly, CCHF was previously identified at the Global Fever panel febrile illness study site in Mubende, Uganda 12,23 . During the 2022 Sudan virus disease outbreak.…”
Section: Discussionmentioning
confidence: 57%
“…If HIV testing was positive, urine lipoarabinomannan (Abbott TB LAM Ag, Illinois, United States) testing was performed. The Biofire FilmArray Global Fever polymerase chain reaction (PCR) panel (Biofire, Utah, USA) was run on whole blood samples to identify 19 bacterial, viral, or protozoal targets or plasma if whole blood was unavailable (first 36 participants) 12 . Plasma samples were run in duplicate with a Crimean-Congo hemorrhagic fever virus real-time RT-PCR assay targeting the NP gene using previously described methods [13][14][15] but replaced after transition of the Global Fever panel from off-site to on-site use after the first 237 participants.…”
Section: Methodsmentioning
confidence: 99%
“…The global population growth during this period might have outpaced the increase in malaria cases, contributing to the decline in ASIR. Besides the gold standard for diagnosing malaria – microscopy of thick and thin blood films [ 24 ], other methods include malaria rapid diagnostic tests [ 25 ], parasite lactate dehydrogenase (pLDH) rapid diagnostic tests [ 24 ], and nucleic acid testing [ 26 ]. As diagnostic criteria and technologies have evolved over time, they have impacted the reporting of malaria cases, which in turn might have led to more accurate and widespread detection of malaria cases, consequently influencing the total reported case numbers.…”
Section: Discussionmentioning
confidence: 99%
“…There are several commercial nucleic acid amplification assays designed for use in acute febrile illness etiology determination that aim to identify a broad set of etiologies. These include the BioFire FilmArray Global Fever Panel (19 pathogens)[ 45 ], Verigene, VerePLEX (26 pathogens)[ 46 ], and FeverDisk (12 pathogens) [ 47 ]. We selected custom-made cards as the ability to select pathogens of regional interest was seen as an important asset in responding to local clinicians’ needs assessment, and because acute febrile illness surveillance and emerging infectious diseases surveillance are overlapping tasks in our laboratory.…”
Section: Discussionmentioning
confidence: 99%